Advanced imaging techniques for understanding idiopathic intracranial hypertension
Official title: Pathophysiological Evaluation of Idiopathic Intracranial Hypertension Using Glymphatic and Connectomic Imaging
Run by Thomas Jefferson University · NCT06950099 · Data updated 2026-11-12
This study is testing advanced imaging techniques on patients with stubborn idiopathic intracranial hypertension to see how stenting affects their brain fluid flow and overall condition.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 55 Years |
| Sex | All |
| Enrollment | 30 (estimated) |
| Sponsor | Thomas Jefferson University Academic / other |
| Locations | 1 site (Philadelphia, Pennsylvania) |
| Status | Recruiting |
| Started | March 3, 2025 |
| Main results expected | December 31, 2025 |
| Study ends | December 31, 2025 |
| Registry record updated | May 2, 2025 |
| Trial ID | NCT06950099 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are patients with refractory idiopathic intracranial hypertension who are planning to undergo venous sinus stenting.
✕Probably not a fit
Patients with a history of head trauma, shunting or leak repair, or those with contraindications for MRIs may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study focuses on patients with refractory idiopathic intracranial hypertension (IIH) who are scheduled to undergo venous sinus stenting. It aims to evaluate advanced neuroimaging metrics, particularly using MRI and diffusion tensor imaging, to gain insights into the pathophysiology of IIH and the effects of stenting on glymphatic function. By assessing cerebrospinal fluid dynamics and venous outflow, the study seeks to identify potential surrogate markers that could enhance understanding and treatment of IIH. The research will be conducted at the Jefferson Headache Center in Philadelphia, Pennsylvania.
Why it matters
Potential benefit: If successful, this study could lead to improved diagnostic and therapeutic strategies for patients suffering from idiopathic intracranial hypertension.
How similar studies have gone: While the specific approach of using advanced neuroimaging in this context may be novel, similar studies have shown promise in understanding cerebrospinal fluid dynamics and treatment outcomes in related conditions.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: • Refractory IIH patients who require and plan to have a venous sinus stenting Exclusion Criteria: * History of head trauma and shunting or leak repair * Major concurrent, active non-cephalic pain syndrome * Contradictions for MRIs
Where it's running
-
Jefferson Headache Center
Philadelphia, Pennsylvania, United States Recruiting
Study contacts
- Principal investigator: Hsiangkuo Yuan, MD PhD — Thomas Jefferson University
- Study coordinator: Enchao Qiu, MD PhD
- Email: enchao.qiu@jefferson.edu
- Phone: 215-955-1149
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
NAIF 2.0: See if glymphatic flow changes after dAVF treatment
This study tests whether the brain’s waste-clearance system changes after endovascular treatment for intracranial dural arteriovenous fistulas in adults.
-
Sleep and Brain Clearance Test with a Wireless Sleep-Boosting Headband
This study tests whether a wireless headband that tracks brain activity and delivers gentle stimulation can improve sleep-dependent brain clearance and memory in healthy adults.
-
Bright light therapy to help sleep after brain injury
This trial tests whether morning bright light therapy can improve sleep and related brain health markers in adults with a traumatic brain injury.
-
Tirzepatide for Idiopathic Intracranial Hypertension
This trial tests whether tirzepatide can help people with idiopathic intracranial hypertension by comparing it to placebo over 12 months.
-
Transverse sinus stenting for people with long-term intracranial hypertension on acetazolamide
This trial will test whether adding a stent in the narrowed transverse sinus helps adults with idiopathic intracranial hypertension who have been on acetazolamide for over a year but still have symptoms.
-
Transverse sinus stenting for newly diagnosed idiopathic intracranial hypertension
This will test whether adding transverse venous sinus stenting to standard medical care helps adults with newly diagnosed idiopathic intracranial hypertension improve vision, headaches, or tinnitus.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.